1Park CH, Bergsagel DE, McCulloch EA. Mouse myeloma tumor stem cells: a primary cell culture assay [ J ]. J Natl Cancer Inst, 1971,46:411 -422.
2Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell[J]. Nat Med, 1997, 3:730-737.
3Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human a2 cute myeloid leukemia after transplantation into SCID mice[J]. Nature, 1994, 367:645-648.
4Jamieson CH, AiUes LE, Dylla S J, et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis[J]. N Engl J Med, 2004, 351:657 -667.
5Ishikawa F, Yoshida S, Saito Y, et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region [ J ]. Nat Biotechnol, 2007, 25:1315 - 1321.
6Kelly PN, Dakic A, Adams JM, et al. Tumor growth need not be driven by rare cancer stem cells [ J ]. Science, 2007, 317:337.
7Zhao C, Blum J, Chen A, et al. Loss of beta-Catenin impairs the renewal of normal and CML stem cells in vivo[ J ]. Cancer Cell, 2007, 12:528 - 541.
8Krivtsov AV, Armstrong SA. MLL transloeations, histone modifications and leukaemia stem-cell development [ J ]. Nat Rev Cancer, 2007, 7:823 -833
9van Rhenen A, van Dongen GA, Kelder A, et al. The novel AML stem cell associated antigen CLL-1 aids in discrimina- tion between normal and leukemic stem cells [ J ]. Blood, 2007, 110:2659-2666.
10Stubbs MC, Armstrong SA. Therapeutic implications of leukemia stem cell development [ J ]. Clin Cancer Res, 2007, 13:3439 - 3442.
